Andere talen Evelo Biosciences, Inc.

Aandelen

EVLO

US2997342025

Beurs gesloten - OTC Markets Andere beurzen 15:30:00 30-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,0495 ^USD	+18,14%		+16,47%	-19,51%

2023	Evelo Biosciences, Inc. kondigt aan dat Simba Gill stopt als Chief Executive Officer	CI
2023	Evelo Biosciences, Inc. kondigt wijzigingen aan in het management, met ingang van 1 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

North American Morning Briefing : More Tech -2-	25/04
North American Morning Briefing : Stock Futures Edge Lower Ahead of PPI Inflation Gauge	11/04
North American Morning Briefing : Focus Turns to -2-	04/04
North American Morning Briefing : Stocks Set for -2-	28/03
North American Morning Briefing : Investors -2-	21/03
Evelo Biosciences, Inc.(OTCPK:EVLO) dropped from S&P TMI Index	14/12
Evelo Biosciences, Inc.(OTCPK:EVLO) dropped from NASDAQ Biotechnology Index	11/12
Evelo Biosciences, Inc.(OTCPK:EVLO) dropped from NASDAQ Composite Index	11/12
Evelo Biosciences, Inc. Announces Marella Thorell Cease as Chief Financial Officer, Effective on December 1, 2023	21/11
Evelo Biosciences, Inc. Announces Simba Gill Ceases as Chief Executive Officer	21/11
Evelo Biosciences, Inc. Announces Executive Changes, Effective December 1, 2023	21/11
Evelo Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09/11
Sector Update: Health Care Stocks Retreat in Late Afternoon	17-10-23
Sector Update: Health Care	17-10-23
Top Midday Decliners	17-10-23
Sector Update: Health Care Stocks Mixed Pre-Bell Tuesday	17-10-23
Evelo Biosciences Says Phase 2 Trial of Psoriasis Treatment Did Not Meet Primary Endpoint; Shares Plunge Pre-Bell	17-10-23
Evelo Biosciences Announces Top-Line Results From its Phase 2 Clinical Study with EDP2939 in Moderate Psoriasis	17-10-23
Evelo Biosciences, Inc. Announces Top-Line Results From its Phase 2 Clinical Study with EDP2939 in Moderate Psoriasis	17-10-23
Medicenna Therapeutics Appoints Humphrey Gardner as Chief Medical Officer	10-10-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Evelo Biosciences, Inc.

Aandelen

EVLO

US2997342025

Andere talen

Filters